Michael Boyd

This inventor holds 10 USPTO granted patents, plus 1 CIPO patent and 9 EPO patents. Top assignees: Merck Frosst Canada & Co., Merck Canada Inc., Merck Frosst Canada, Inc.. Active years: 2002-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Boyd. Retrieved from https://idiyas.com/inventor/michael-boyd-f6913ih5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 9 (Patent Applications = 2)

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 85(Granted Patents)

Location History:

Pointe-Claire, CA (2003)
Montreal, CA (2002 - 2011)
Saint-Lazare, CA (2012 - 2014)

Company Filing History:

4 out of 80

Merck Frosst Canada & Co.

Merck Frosst Canada, Inc.

patents

4. 2 out of 2,405

Merck Sharp + Dohme Corp.

patents

Years Active: 2002-2014

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8685999 - Beta carboline sulphonylurea derivatives as EP4 receptor antagonists (2014-04-01),

2. 8637671 - Indole derivatives as CRTH2 receptor antagonists (2014-01-28),

3. 8394819 - Indole derivatives as CRTH2 receptor antagonists (2013-03-12),

4. 8158671 - Indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonists (2012-04-17),

5. 7968578 - Indole amide derivatives as EP4 receptor antagonists (2011-06-28),

6. 7705035 - Indoline amide derivatives as EP4 receptor ligands (2010-04-27),

7. 7687524 - Cathepsin cysteine protease inhibitors (2010-03-30),

8. 7279478 - Cathepsin cysteine protease inhibitors (2007-10-09),

9. 6583126 - Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) (2003-06-24),

10. 6410583 - Cyclopentanoindoles, compositions containing such compounds and methods of treatment (2002-06-25),

Hello! How may I help you today in innovations, inventions, inventors, patent attorneys, assignees or patents?

Profile summary based on public USPTO records.